The Medicines and Healthcare products Regulatory Agency (MHRA) approved marketing authorisation for Mounjaro, a new treatment, to treat type 2 diabetes in adults. This authorization comes after positive results from clinical trials that showed Mounjaro effectively reduces blood sugar levels in patients. Mounjaro functions as a once-weekly injectio